In our study we aimed at evaluating the expression of LCN and BCL2L2, in newly diagnosed bone marrow samples from adult with AML and to correlate their expression levels with clinical and Laboratory data of the patients, especially those known to have a prognostic feature. Here, BCL2L2 is linked to acute myeloid leukemia.